Patient reported outcomes before March, in June and in November 2020 in patients with IRD. N=7,836
| Before* | June 2020 | Nov 2020 | |
| Patient VAS global, mm | 30 (12-58) | 28 (10-54) | 29 (10-55) |
| Patient VAS pain, mm | 27 (11-51) | 28 (11-51) | 29 (11-52) |
| HAQ | 0.50 (0.13-1.0) | 0.50 (0.13-1.00) | 0.50 (0.13-1.00) |
| EQ-5D | 0.80 (0.72-0.86) | 0.79 (0.71-0.86) | 0.80 (0.71-0.86) |
| PASS, yes | 73% | 75% | 76% |
Numbers are median (IQR) unless otherwise stated*Latest registration in DANBIO before March 2020Patient characteristics for RA/AxSpA/PsA/Other: female, %: 70/53/44/69. Age, years, median(IQR): 67(59-74)/62(54-69)/56(46-65)/59(50-68)Abbreviations: EQ-5D: Quality of life, 5 dimensions, HAQ: health assessment questionnaire, PASS: patient acceptable symptom state, VAS: visual analogue scale